“…Earlier generations of pegylated benzothiazole derivatives were shown to increase post‐synaptic spine densities and functional synapses via an F‐actin cytoskeleton‐dependent mechanism (Cifelli et al., 2016; Lee et al., 2016; Zhang et al., 2019). While the effect of SPG302 and prototype compounds on spinal cord injury remains unknown, prior studies demonstrate the importance of glutamatergic receptors in improving recovery following C 2 SH (ElMallah et al., 2015; Gransee et al., 2017; Mantilla et al., 2012; Rana, Sieck et al., 2020; Wollman et al., 2020) and the presence of dendritic spines on spinal motor neurons (Bandaru et al., 2015; Fogarty, Mu et al., 2017, Fogarty et al, 2020b).…”